LLY
StockEli Lilly and Co
- HQ
- US
- Sector
- Pharmaceuticals
- Issued
- 1985-01-13
- Shares out.
- 942M
Performance
57 min agoKey statistics
57 min ago- Market cap
- $1.01T
- Enterprise value
- $1.04T
- P/E (TTM)
- 39.81
- Forward P/E
- 27.51
- P/E (annual)
- 48.75
- PEG
- 1.37
- P/B
- 38.29
- P/S (TTM)
- 13.93
- P/S (annual)
- 15.44
- EV / EBITDA
- 31.11×
- EV / Revenue
- 14.45×
- EPS (TTM)
- $28.15
- EPS (annual)
- $22.95
- Basic EPS (TTM)
- $28.15
- Book value / share
- $28.09
- Gross margin
- 82.83%
- Operating margin
- 43.63%
- Net margin
- 34.99%
- Return on equity (ROE)
- 101.31%
- Return on assets (ROA)
- 22.73%
- Return on investment (ROI)
- 37.71%
- EBITDA / share
- $37.37
- Revenue / share (TTM)
- $80.64
- Revenue growth (TTM YoY)
- +47.44%
- Revenue growth (Q YoY)
- +55.55%
- EPS growth (TTM YoY)
- +128.83%
- Dividend yield (indicated)
- 0.64%
- Dividend yield (TTM)
- 0.56%
- Dividend / share (TTM)
- $5.91
- Payout ratio
- 22.10%
- Current ratio
- 1.58
- Quick ratio
- 0.78
- Debt / equity
- 1.60
- LT debt / equity
- 1.54
- Beta
- 0.52
- Volatility (3M)
- 37.57%
Analyst ratings
57 min agoEarnings
57 min agoRelated news
57 min ago- Yahoo·6 d agocompanyThe $4 Billion Reason Eli Lilly Stock Is Up Today
Eli Lilly shares inch higher as the company announced three acquisitions for nearly $4 billion. Here’s why each of the three vaccine makers it’s buying is bullish for LLY stock.
- Yahoo·6 d agocompanyEli Lilly to Expand Vaccine Pipeline With Three Biotech Buyouts
LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes.
- Yahoo·6 d agocompanyLilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference
Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health, will take part in a fireside chat at 3:20 p.m. Eastern time.
- Yahoo·6 d agocompanyNovo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?
NVO and AMGN square off as GLP-1 leadership, pipeline depth and diversification shape a compelling healthcare stock comparison.
- Yahoo·6 d agocompanyMarket Minute 5-27-26- The $1 TLN Club Keeps Growing
Crude oil, gold, and silver are all sliding to start the day, while equities are up a smidge. Treasuries and the dollar are mostly flat, while Bitcoin continues to mark time in the mid-$70,000s.
- Yahoo·6 d agocompanyHere's Why Eli Lilly (LLY) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Yahoo·6 d agocompanyKailera’s three-pronged obesity shot shows promise in early trial
As Lilly completes the pivotal program for its “triple-G” drug, Phase 1 data from Kailera partner Hengrui suggest their offering might spur greater weight loss.
- SeekingAlpha·6 d agocompanySouth Korea: Asia's Second Innovation Engine
South Korea has been the second most important contributor to the growth of Asian innovation in recent years, outperforming Japan in several areas. Read more here.
